IP Library › Assignment 029766/0373
Patent Assignment
Reel/Frame 029766/0373

Merger

Recorded: 2013-02-06 Pages: 9
Assignor
SAPPHIRE THERAPEUTICS, INC.
Executed: 2008-12-18
Assignee
HELSINN THERAPEUTICS (U.S.), INC.
1160 U.S. HIGHWAY 22, SUITE 104, BRIDGEWATER, NEW JERSEY, 08807
Covered Property (1)
Methods of Treating Emesis Using Growth Hormone Secretagogues
Patent: 8,394,833 →
Application: 13/476,111 →
Publication: US 2012/0232113
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 6, 2013
From: MANN, WILLIAM R.; POLINO, WILLIAM J.
To: SAPPHIRE THERAPEUTICS
Reel/Frame 029762/0803 →
Assignment of Assignor's Interest Oct 28, 2015
From: HELSINN THERAPEUTICS (U.S.), INC.
To: HELSINN HEALTHCARE SA
Reel/Frame 036903/0809 →
Corrective Assignment to Correct the Country of the Assignee's Address Previously Recorded on Reel 036903 Frame 0809. Assignor(S) Hereby Confirms the Correct Country of the Assignee's Address. Dec 14, 2015
From: HELSINN THERAPEUTICS (U.S.), INC.
To: HELSINN HEALTHCARE SA
Reel/Frame 037288/0749 →